Zhitong Finance App News, Sunflower (300111.SZ) issued an announcement. Zhejiang Beide Pharmaceutical Co., Ltd., a subsidiary of the company, recently received the “Drug Registration Certificate” for glucosamine sulfate capsules issued by the State Drug Administration. The drug is suitable for primary and secondary osteoarthritis. Obtaining a “Drug Registration Certificate” this time is considered to have passed the consistency evaluation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.